510 related articles for article (PubMed ID: 23969737)
1. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning.
Kwong PD; Mascola JR; Nabel GJ
Nat Rev Immunol; 2013 Sep; 13(9):693-701. PubMed ID: 23969737
[TBL] [Abstract][Full Text] [Related]
2. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
Sadanand S; Suscovich TJ; Alter G
Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
[TBL] [Abstract][Full Text] [Related]
3. Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
Stephenson KE; Wagh K; Korber B; Barouch DH
Annu Rev Immunol; 2020 Apr; 38():673-703. PubMed ID: 32340576
[TBL] [Abstract][Full Text] [Related]
4. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.
Kwong PD; Mascola JR; Nabel GJ
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a007278. PubMed ID: 22229123
[TBL] [Abstract][Full Text] [Related]
5. In vivo protection by broadly neutralizing HIV antibodies.
van Gils MJ; Sanders RW
Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
[TBL] [Abstract][Full Text] [Related]
6. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.
Verkoczy L; Kelsoe G; Moody MA; Haynes BF
Curr Opin Immunol; 2011 Jun; 23(3):383-90. PubMed ID: 21524897
[TBL] [Abstract][Full Text] [Related]
7. The Neutralizing Antibody Response to the HIV-1 Env Protein.
Moore PL
Curr HIV Res; 2018; 16(1):21-28. PubMed ID: 29173180
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies and control of HIV: moves and countermoves.
Hessell AJ; Haigwood NL
Curr HIV/AIDS Rep; 2012 Mar; 9(1):64-72. PubMed ID: 22203469
[TBL] [Abstract][Full Text] [Related]
9. Toward an antibody-based HIV-1 vaccine.
Hoxie JA
Annu Rev Med; 2010; 61():135-52. PubMed ID: 19824826
[TBL] [Abstract][Full Text] [Related]
10. A vaccine strategy for inducing broadly neutralizing antibodies against HIV.
Marchal I
Nat Biotechnol; 2024 Jun; 42(6):847. PubMed ID: 38886609
[No Abstract] [Full Text] [Related]
11. HIV Vaccines: One Step Closer.
Low MSY; Tarlinton D
Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
Montefiori DC; Mascola JR
Curr Opin HIV AIDS; 2009 Sep; 4(5):347-51. PubMed ID: 20048696
[TBL] [Abstract][Full Text] [Related]
13. Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012.
Girard MP; Picot V; Longuet C; Nabel GJ
Vaccine; 2013 Jun; 31(29):2979-83. PubMed ID: 23499518
[TBL] [Abstract][Full Text] [Related]
14. Recent strategies targeting HIV glycans in vaccine design.
Horiya S; MacPherson IS; Krauss IJ
Nat Chem Biol; 2014 Dec; 10(12):990-9. PubMed ID: 25393493
[TBL] [Abstract][Full Text] [Related]
15. Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
Moore PL; Williamson C; Morris L
Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881
[TBL] [Abstract][Full Text] [Related]
16. Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
Ahmed Y; Tian M; Gao Y
AIDS Res Ther; 2017 Sep; 14(1):50. PubMed ID: 28893278
[TBL] [Abstract][Full Text] [Related]
17. HIV vaccine development--improving on natural immunity.
Johnston MI; Fauci AS
N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
[No Abstract] [Full Text] [Related]
18. Immunological mechanisms of inducing HIV immunity in infants.
Fouda GG; De Paris K; Levy O; Marchant A; Gray G; Permar S; Marovich M; Singh A
Vaccine; 2020 Jan; 38(3):411-415. PubMed ID: 31761501
[TBL] [Abstract][Full Text] [Related]
19. A critical question for HIV vaccine development: which antibodies to induce?
Zolla-Pazner S
Science; 2014 Jul; 345(6193):167-8. PubMed ID: 25013066
[TBL] [Abstract][Full Text] [Related]
20. HIV neutralizing antibodies: clinical correlates and implications for vaccines.
Doria-Rose NA
J Infect Dis; 2010 Apr; 201(7):981-3. PubMed ID: 20170372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
